Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension

Research output: Contribution to journalReview articlepeer-review

30 Scopus citations

Fingerprint Dive into the research topics of 'Ambrisentan, an endothelin receptor type A-selective endothelin receptor antagonist, for the treatment of pulmonary arterial hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences